These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 561288)

  • 1. Office treatment of anaerobic infections.
    Bartlett JG
    Med Times; 1977 Sep; 105(9):16d (130)-8d (130). PubMed ID: 561288
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaerobic infection in the neutropenic host: anti-endotoxin effect of polymyxin.
    Bannatyne RM; Cheung R
    Anticancer Res; 1984; 4(3):169-70. PubMed ID: 6087717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increase of anaerobic infections. Prevalence of Bacteroides. Apropos of 17 cases in abdominal surgery].
    Coulbois B; Legall N; Blondel P; Riche D; Curtet N; Guesnon P; Guéry J
    Anesth Analg (Paris); 1977; 34(2):367-79. PubMed ID: 900536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in the female genital tract.
    Gall SA
    Compr Ther; 1983 Aug; 9(8):34-47. PubMed ID: 6413123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracyclines in gynecologic infections.
    Ledger WJ
    Bull N Y Acad Med; 1978 Feb; 54(2):196-204. PubMed ID: 272213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
    Itokazu GS; Danziger LH
    Pharmacotherapy; 1991; 11(5):382-414. PubMed ID: 1745624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiologic considerations in the treatment of serious pelvic infections in women.
    Venezio FR; O'Keefe JP
    J Reprod Med; 1988 Jan; 33(1 Suppl):124-7. PubMed ID: 3278108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole hydrochloride (Flagyl I.V.).
    Med Lett Drugs Ther; 1981 Feb; 23(4):13-4. PubMed ID: 7464682
    [No Abstract]   [Full Text] [Related]  

  • 10. Parallel study of two techniques for identification of gram negative anaerobic bacilli.
    Nadaud M; Cancet B
    Zentralbl Bakteriol Orig A; 1977 Apr; 237(4):530-5. PubMed ID: 325953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.
    Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez H
    Antimicrob Agents Chemother; 2006 Jan; 50(1):148-55. PubMed ID: 16377680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infections caused by gramnegative anaerobic bacteria].
    Werner H
    Med Klin; 1975 Nov; 70(47):1899-04. PubMed ID: 765703
    [No Abstract]   [Full Text] [Related]  

  • 13. The identification of gram-negative anaerobic bacilli isolated from clinical infections.
    Duerden BI
    J Hyg (Lond); 1980 Apr; 84(2):301-13. PubMed ID: 6987300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anaerobic infections--how important are these in general practice?].
    Aass PO
    Tidsskr Nor Laegeforen; 1981 Jul; 101(19-21):1128-32. PubMed ID: 7281138
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of gram negative anaerobic bacilli in routine clinical specimens.
    De A; Gogate A
    Indian J Pathol Microbiol; 2001 Oct; 44(4):435-8. PubMed ID: 12035357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anaerobic infections II. Bacteriological study and treatment].
    Schreiner A; Solberg CO
    Tidsskr Nor Laegeforen; 1976 Feb; 96(6):378-9. PubMed ID: 1257978
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anaerobic sepsis].
    Russu VG
    Klin Med (Mosk); 1983 Nov; 61(11):11-7. PubMed ID: 6141318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.